1. Siegfried N, Uthman OA, Rutherford GW. Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev. 2010;2010(3):CD008272–008272.
2. HIV.gov. Global Statistics [Internet]. HIV.gov. 2020 [cited 2020 Aug 29]. https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics.
3. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating. and preventing HIV infection [Internet]. Geneva, Switzerland: World Health Organization; 2016 [cited 2020 Aug 2] p. v. https://apps.who.int/iris/bitstream/handle/10665/208825/9789241549684_eng.pdf;jsessionid=E90C74EFE806AA7EB5273E885C28B7A1?sequence=1.
4. Grimsrud A, Lesosky M, Kalombo C, Bekker LG, Myer L. Implementation and Operational Research: Community-Based Adherence Clubs for the Management of Stable Antiretroviral Therapy Patients in Cape Town, South Africa: A Cohort Study. JAIDS J Acquir Immune Defic Syndr [Internet]. 2016;71(1). https://journals.lww.com/jaids/Fulltext/2016/01010/Implementation_and_Operational_Research_.18.aspx.
5. Columbia University. Rwanda Population -based HIV Impact Assessment (RPHIA): 2018–2019 [Internet]. ICAP. 2019 Dec [cited 2020 Oct 30] p. 6. https://phia.icap.columbia.edu/wp-content/uploads/2019/10/RPHIA-Summary-Sheet_Oct-2019.pdf.